Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetic Kidney Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06792448
What this trial is testing

Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study

Who this might be right for
Nephrotic Syndrome Steroid-DependentNephrotic Syndrome Steroid-ResistantNephrotic Syndrome in Children+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 350
Not applicableStudy completedNCT05076318
What this trial is testing

Dysregulated Urea-synthesis at Terminal Uremia

Who this might be right for
Urea Cycle DisorderUremia
University of Aarhus 10
Testing effectiveness (Phase 2)Looking for participantsNCT04322318
What this trial is testing

Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Who this might be right for
Anaplastic Kidney Wilms TumorRecurrent Kidney Wilms TumorStage II Kidney Wilms Tumor+2 more
Children's Oncology Group 256
Testing effectiveness (Phase 2)Study completedNCT04987242
What this trial is testing

An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201)

Who this might be right for
HyperuricemiaGoutChronic Kidney Diseases
Allena Pharmaceuticals 16
Large-scale testing (Phase 3)Study completedNCT02225860
What this trial is testing

Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Tufts Medical Center 34
Not applicableStudy completedNCT05923788
What this trial is testing

T1 Mapping in Fabry Disease

Who this might be right for
Fabry Disease
Hospices Civils de Lyon 70
Testing effectiveness (Phase 2)Looking for participantsNCT05478083
What this trial is testing

A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease

Who this might be right for
Polycystic Liver DiseaseAutosomal Dominant Polycystic Kidney
University Medical Center Groningen 36
Testing effectiveness (Phase 2)Study completedNCT03366337
What this trial is testing

Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

Who this might be right for
IgA NephropathyCKD Associated With Type 1 DiabetesFocal Segmental Glomerulosclerosis+1 more
Biogen 103
Early research (Phase 1)Study completedNCT03096080
What this trial is testing

A Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Who this might be right for
Polycystic Kidney, Autosomal Recessive
Kadmon Corporation, LLC 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03401788
What this trial is testing

Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)

Who this might be right for
VHL - Von Hippel-Lindau SyndromeVHL Gene MutationVHL Syndrome+3 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 50
Not applicableUnknownNCT05843851
What this trial is testing

Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria

Who this might be right for
CystinosisPrimary Hyperoxaluria
Cystinose Stiftung 200,000
Not applicableStudy completedNCT02112136
What this trial is testing

Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
University Hospital, Brest 1,450
Not applicableLooking for participantsNCT07036731
What this trial is testing

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Large-scale testing (Phase 3)UnknownNCT04872907
What this trial is testing

Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCT

Who this might be right for
X-linked Hypophosphatemia (XLH)
Assistance Publique - Hôpitaux de Paris 60
Not applicableStudy completedNCT01549080
What this trial is testing

Study of Effects of YisuiShengxueGranules on Thalassemia

Who this might be right for
Thalassemia
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 2
Not applicableEnrolling By InvitationNCT06910475
What this trial is testing

Physical Exercise and Biomolecular Analysis to Reduce Uremic Toxins in Chronic Kidney Disease: An Exploratory Study

Who this might be right for
Kidney Disease, ChronicKidney Failure Chronic
Catholic University of Brasília 1,600
Not applicableStudy completedNCT01652573
What this trial is testing

Calcitonin for Treating X-linked Hypophosphatemia

Who this might be right for
Hypophosphatemic Rickets, X Linked Dominant
Yale University 21
Not applicableStudy completedNCT00004305
What this trial is testing

Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis

Who this might be right for
IGA Glomerulonephritis
National Center for Research Resources (NCRR) 105
Testing effectiveness (Phase 2)Study completedNCT01479439
What this trial is testing

Losartan to Reverse Sickle Nephropathy

Who this might be right for
NephropathySickle Cell Anemia
Children's Hospital Medical Center, Cincinnati 36
Testing effectiveness (Phase 2)Study completedNCT00061763
What this trial is testing

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

Who this might be right for
Beta-thalassemiaMyelodysplastic SyndromesFanconi Syndrome+2 more
Novartis Pharmaceuticals 175
Next Page